Stryker Corporation (SYK)
What changed in recent filings
- Institutions — 5 new · 1 added · 1 reduced13F · as of end of 2026 Q2
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Institutions holding Stryker Corporation
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 2 → 2026 Q2: 7 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold Stryker Corporation
Institutions we track that reported holding this stock in their most recent 13F.
- Bridgewater Associates0.02% of portfolio · since 2020 Q1
- Point72 Asset Management0.15% of portfolio · since 2026 Q1
- Caisse de depot (Quebec)under 0.01% of portfolio · held as of 2026 Q2 or earlier
- Fundsmith6.72% of portfolio · held as of 2026 Q2 or earlier
- National Pension Service (Korea)0.15% of portfolio · held as of 2026 Q2 or earlier
- Generation Investment Management1.57% of portfolio · held as of 2026 Q2 or earlier
- PRIMECAP Management0.13% of portfolio · held as of 2026 Q2 or earlier
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Company overview
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
Stryker Corporation is classified under the Biotech & Health sector. See peers below.
ETFs holding Stryker Corporation
Per SEC N-PORT · 2026-06-30 · by weight · factual
SYK on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
SYK FAQ
What is Stryker Corporation (SYK)?
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
What sector is Stryker Corporation in?
Stryker Corporation is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
Where can I analyze Stryker Corporation (SYK) stock?
On Stocklore you can see SYK's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.